Documentos de Académico
Documentos de Profesional
Documentos de Cultura
Project
Gene Therapy
Name: OV Shashank
Class: XII D
Roll No:
Certificate
Year: 2013-14
This is to certify that OV Shashank a
student of RN Podar School, of class XIID, Roll No:
, has completed his
full semester project in the fulfilment of
curriculum All India Senior Secondary
Examination
The project work entitled Gene
_____________________
___________________
Internal Examiner
Principal
______________________
External Examiner
School Stamp
Acknowledgement
I take this opportunity to express my
sincere gratitude to the honourable Principal
Mrs Avnita Bir of RN Podar School for her
deep interest and guidance provided to me
during the course.
I am most grateful to our Biology teacher
Mrs Padmavathi for her great help in the
completion of this project.
Students Signature
__________________________
Table of Contents
Introduction
Gene Therapy
Targets
Isolation of gene
Gene Targeting
Gene Delivery
Case Study Cystic Fibrosis
The Disease
3
Is it a good Target
Choosing Vectors
History
Challenges
Ethical Issues
Recent Upcoming
CRISPR
Conclusion
Bibliography
Websites
Books
Introduction
Diseases
The term disease broadly refers to any condition that impairs normal function, and is
therefore associated with dysfunction of normal homeostasis. When the functioning
of one or more organs or systems of the body is adversely affected, characterised by
various signs and symptoms, we say that we are not healthy, i.e., we have a
disease.
Health can be defined as a state of complete physical, mental and social well-being.
When people are healthy, they are more efficient at work. This increases productivity
and brings economic prosperity. Health also increases longevity of people and
reduces infant and maternal mortality.
Infections
These are diseases caused due to invasion of a foreign
parasitic organism. They are temporary because the immune
system of organisms can fight such pathogens (disease
causing organisms) to a certain extent hence helping in
prevention of the disease. The immune system can also be
aided with the use of several drugs. Apart from easy
treatment they can also be easily prevented
Lifestyle Diseases
Lifestyle diseases (also sometimes called diseases of longevity or diseases of
civilization interchangeably) are diseases that appear to increase in frequency as
countries become more industrialized and people live longer. They can
include Alzheimer's disease, asthma, and obesity. Diet and lifestyle are major factors
thought to influence susceptibility to many diseases. Drug abuse, tobacco smoking,
and alcohol drinking, as well as a lack of exercise may also increase the risk of
developing certain diseases, especially later in life. These diseases can be
prevented completely by living a healthy lifestyle.
Genetic Disorders
A genetic disorder is an illness caused by one or more abnormalities in the
genome, especially a condition that is present from birth (congenital). They are
medical disorders related to gene mutation.
Genetic disorders are heritable, and are passed down from the parents' genes.
Other defects may be caused by new mutations or changes to the DNA. In such
cases, the defect will only be heritable if it occurs in the germ line. The
same disease, such as some forms of cancer, may be caused by an inherited
genetic condition in some people, by new mutations in other
people, and by non-genetic causes in still other people.
These diseases are totally random and difficult to
prevent as they are not caused by external agents. Also
as their
root cause lies in the genome of the organism their cure
was thought to be impossible until the breakthrough research unlocking the secrets
of DNA leading to the development of biotechnology and hence gene therapy.
Gene Therapy
We can think of a medical condition or
illness as a "broken window." Many medical
conditions result from flaws, or mutations, in
one or more of a person's genes. Mutations
cause the protein encoded by that gene to
malfunction. When a protein malfunctions,
cells that rely on that protein's function can't
behave normally, causing problems for
whole tissues or organs. Medical conditions
related to gene mutations are called genetic
disorders.
So, if a flawed gene caused our "broken window," can we "fix" it? What are our
options?
1. Stay silent: ignore the genetic disorder and nothing gets fixed.
2. Try to treat the disorder with drugs or other approaches: depending on the
disorder, treatment may or may not be a good long-term solution.
3. Put in a normal, functioning copy of the gene: if you can do this, it may solve
the problem!
If it is successful, gene therapy provides a way to fix a problem at its source. Adding
a corrected copy of the gene may help the affected cells, tissues and organs work
properly. Gene therapy differs from traditional drug-based approaches, which may
treat the problem, but which do not repair the underlying genetic flaw.
but others may not be suitable for this approach. For a disease to be targeted by
gene therapy it must satisfy the following conditions:
1. The condition must result from mutations in one or more genes
2. To treat a genetic flaw, the knowledge of which gene(s) to pursue is
absolutely necessary. Also a DNA copy of that gene available in the
laboratory. The best candidates for gene therapy are the so-called "singlegene" disorders - which are caused by mutations in only one gene.
3. To design the best possible approach, knowledge about how the gene
factors into the disorder is required. For example:
What role does the protein encoded by the gene play within the cells of
that tissue?
4. Adding a normal copy of the gene should fix the problem in the affected
tissue. This may seem like obvious, but it's not. What if the mutated gene
encodes a protein that prevents the normal protein from doing its job? Mutated
genes that function this way are called dominant negative and adding back the
normal protein won't fix the problem.
5. The gene delivery to cells of the affected tissue must be possible. It
depends on:
The techniques of biotechnology have made it possible to isolate the required gene
in the laboratory and also deliver the gene.
scientific research into the identity and function of useful genes. Once that is known
the DNA needs to be cut at specific locations to isolate the gene of interest. This can
be done by using restriction enzymes also known as molecular scissors which cut
DNA at specific sites containing palindromic DNA sequences. But in order to cut the
DNA with restriction enzymes, it needs to be in pure form, free from other macromolecules.
Isolation of DNA
Since the DNA is enclosed within the membranes, we have to break the cell open to
release DNA along with other macromolecules such as RNA, proteins,
polysaccharides and also lipids. This can be achieved by
treating the bacterial cells/plant or animal tissue with
enzymes such as lysozyme (bacteria), cellulase (plant
cells), chitinase (fungus). Genes are located on long
molecules of DNA intertwined with proteins such as
histones. The RNA can be removed by treatment with
ribonuclease whereas proteins can be removed by
treatment with protease. Other molecules can be removed
by appropriate treatments and purified DNA ultimately
precipitates out after the addition of chilled ethanol. This can be seen as collection of
fine threads in the suspension.
Cutting of DNA
Restriction enzyme digestions are performed by
incubating purified DNA molecules with the
restriction enzyme, at the optimal conditions for that
specific enzyme. The cutting of DNA by restriction
endonucleases results in the fragments of DNA.
These fragments can be separated by a technique
known as gel electrophoresis. Since DNA
fragments are negatively charged molecules they
can be separated by forcing them to move towards
the anode under an electric field through a medium/matrix. The separated bands of
DNA are analysed for the required gene and then it is cut out from the agarose gel
and extracted from the gel piece. This step is known as elution.
Gene Targeting
Gene delivery is one of the biggest challenges in the field of gene therapy.
Gene Delivery includes:
1. TARGETING the right cells.
2. ACTIVATING the gene. A gene's journey is not over when it enters the cell. It
must go to the cell's nucleus and be "turned on," meaning that its transcription and
translation are activated to produce the protein product encoded by the gene. For
gene delivery to be successful, the protein that is produced must function properly.
3. INTEGRATING the gene in the cells. The gene must stay put and continue
working in the target cells. If so, it must be ensured that the gene integrates into, or
becomes part of the host cell's genetic material, or that the gene finds another way to
survive in the nucleus without being rejected.
4. AVOIDING harmful side effects. Anytime an unfamiliar biological substance is
introduced into the body, there is a risk that it will be toxic or that the body will mount
an immune response against it. If the body develops immunity against a specific
gene delivery vehicle, future rounds of the therapy will be ineffective.
Viruses
Usually when we think of viruses, we think of them causing diseases such as the
common cold, the flu, and HIV/AIDS. When faced with the problem of gene delivery,
scientists looked to viruses. Why reinvent the wheel if there's a perfectly good one
out there? If we can modify viruses to deliver genes without making people sick, we
may have a good set of gene therapy tools.
General advantages of viral vectors:
-
10
Non-Viral Vectors
Although viruses can effectively deliver genetic material into a patient's cells, they do
have some limitations. It is sometimes more efficient to deliver a gene using a nonviral vector, which has fewer size constraints and which won't generate an immune
response.
Non-viral vectors are typically circular DNA molecules, also known as plasmids. In
nature, bacteria use plasmids to transfer genes from cell to cell.
Scientists use bacteria and plasmids to easily and efficiently store and replicate
genes of interest from any organism.
Vectors used at present, are engineered in such a way that they help easy linking of
foreign DNA and selection of recombinants from non-recombinants.
into
host cells. In a method known as micro-injection, recombinant DNA is directly
injected into the nucleus of an animal cell. In another method, suitable for plants,
cells are bombarded with high velocity micro-particles of gold or tungsten coated with
DNA in a method known as biolistics or gene gun.
11
The first way is to inject the vector into the body and specifically target affected cells.
This is called an in vivo approach. The second way, called ex vivo, is to deliver the
gene to cells while they're outside the body by:
Delivering the genes to the cells (using one of the vector options described
on this page), activating them, and making sure that the cells integrate them
properly.
Case Study
Cystic Fibrosis
The Disease A Genetic Disorder
Cystic fibrosis (CF), also known as mucoviscidosis, is an autosomal recessive
genetic disorder that affects most critically the lungs, and also the pancreas, liver,
and intestine. It is characterized by abnormal transport of chloride and sodium across
an epithelium, leading to thick, viscous secretions, preventing the cilia from clearing
debris which cause symptoms such as coughing, poor digestion and increased
vulnerability to infection.
12
Will adding a normal copy of the gene fix the problem in the
affected tissue? Yes. While the mutated CFTR gene encodes a non-functional ion
channel protein, it will not prevent a normal CFTR channel protein from working
properly. Therefore, adding a normal copy of the CFTR gene should fix the problem
surfaces are exposed to the air and somewhat easy to reach. Because the digestive
system is less accessible, however, it might be a more difficult region to treat.
Hence we can conclude that it is a perfect disease to be treated by gene therapy.
Choosing vectors
The vectors that are most suitable for gene therapy are:
Retrovirus
Retroviruses are enveloped viruses that replicate in a host cell through the process of
reverse transcription. It is a single-stranded RNA virus that stores its nucleic acid in
the form of an mRNA genome targets. Once inside the host cell cytoplasm the virus
uses its own reverse transcriptase enzyme to produce DNA from its RNA genome,
the reverse of the usual pattern, thus retro (backwards). This new DNA is then
incorporated into the host cell genome by an integrase enzyme, at which point the
retroviral DNA is referred to as a provirus. The host cell then treats the viral DNA as
part of its own genome, translating and transcribing the viral genes along with the
cell's own genes, producing the proteins required to assemble new copies of the
virus.
One drawback of retroviruses, such as the Moloney retrovirus, involves the
requirement for cells to be actively dividing for transduction. As a result, cells such as
neurons are very resistant to infection and transduction by retroviruses.
But the airway cells which are affected by the disease cystic fibrosis and must be
targeted divide infrequently. Hence Retrovirus is not a suitable vector for this disease.
Adenovirus
Adenoviruses (members of the family Adenoviridae) are medium-sized (90100 nm),
nonenveloped (without an outer lipid bilayer) viruses with anicosahedral
nucleocapsid containing a double stranded DNA genome.
14
found to
human
Adeno-Associated Viruses
Adeno-associated virus (AAV) is a small virus which infects humans and some
other primate species. AAV is not currently known to cause disease and
consequently the virus causes a very mild immune response.AAV can infect both
dividing and quiescent cells and persist in an extra chromosomal state without
integrating into the genome of the host cell. Despite its few disadvantages these
features make AAV a very attractive candidate for creating viral vectors for gene
therapy, and for the creation of isogenic human disease models
Hence it is the best choice for gene delivery in the case of Cystic Fibrosis.
15
1993
In 1993, the first experimental CF gene therapy treatment was given to a patient with
cystic fibrosis. Researchers modified a common cold Adenovirus to act as a
delivery vehicle by carrying normal genes to the CFTR cells in the nasal passages.
Researchers chose nasal passages as the site of delivery because they are easier to
access and measure gene activity than the lung airway. Later trials delivered the
vector to patients lung airways.
In the earlier trials, it had looked like the virus had entered cells and that the CTFR
gene was working. But later trials with different patients showed levels of VFTR gene
activity that were too low to make any difference. Researchers came to think that the
adenovirus cant easily enter airway cells, especially in the low doses that were being
given. In the earlier trials, they speculated, gene activity resulted from the damage to
the cells during delivery allowing the virus to enter easily.
Hence when higher doses of the virus were tried, the immune system of the patients
started mounting immune responses and fighting off the virus. This caused a
blockage in the trials until 1998.
1998
Trials using Adeno-associated virus to deliver the CTFR gene began in 1998. Unlike the
adenovirus, the Adeno-associated virus caused no immune response or adverse side effects
in patients.
But unlike the researchers predictions, the adeno-associated virus did not enter cells
efficiently and integrate into calls genomic DNA. They produced only low and fleeting
amounts of CFTR gene activity. Researchers are still working to figure out what caused the
viruses to fail.
16
But because it is safe, the virus as we predicted earlier holds promise for being a good
way to deliver the CFTR gene to patients airway cells. But researchers need to learn more
about how the virus infects cells in order or make it an effective delivery method.
Challenges
Some the factors that have kept gene therapy from becoming an effective treatment
for genetic diseases are:
17
Issues regarding
Gene Therapy
What are the possible implications of gene therapy research to society? All of us researchers, policymakers and the public - have a responsibility to explore the
potential effects of gene therapy research on our lives so that we can make informed
decisions.
For each new application of gene therapy research, we must consider:
Legal issues require researchers and the public to help policymakers decide
whether and how gene therapy research should be regulated by the
government.
18
When should gene therapy be used? Should it be used to treat critically ill
patients? Should it be used to treat babies and children?
Recent Upcoming
CRISPR
19
20
Conclusion
Although early clinical failures led many to dismiss gene therapy as over-hyped,
clinical successes since 2006 have bolstered new optimism in the promise of gene
therapy. These include successful treatment of patients with the retinal
disease Leber's congenital amaurosis, X-linked SCID, ADA-SCID,
adrenoleukodystrophy, chronic lymphocytic leukaemia (CLL),acute lymphocytic
leukaemia (ALL),multiple myeloma, haemophilia and Parkinson's disease. These
recent clinical successes have led to a renewed interest in gene therapy, with several
articles in scientific and popular publications calling for continued investment in the
field.
Bibliography
Websites
http://en.wikipedia.org/wiki/Gene_therapy
http://www.trip2medi.com/treatmentCGeneTherapy.php
http://learn.genetics.utah.edu/content/tech/genetherapy/
http://ghr.nlm.nih.gov/handbook/therapy/
http://cystic-fibrosis.emedtv.com/cystic-fibrosis/cystic-fibrosis-genetherapy.html
http://en.wikipedia.org
Books
12th NCERT Biology
Stryer Biochemistry
21